Currently out of the existing stock ratings of Gobind Singh, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).

Gobind Singh

Work Performance Price Targets & Ratings Chart

Analyst Gobind Singh, has had 58.33% of price targets met with an average potential upside of 52.66%, reached in 389 days on average. Previously, Gobind Singh worked at HC WAINWRIGHT, JMP.

Gobind Singh has documented 26 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on IMUX, Immunic at 19-Sep-2022.

Wall Street Analyst Gobind Singh

Analyst best performing recommendations are on EVLO (EVELO BIOSCIENCES).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) on 5/24/2021. The price target of $48 was fulfilled within 57 days with a profit of $12.69 (35.94%), with a performance score of 6.31.

Average potential price target upside

EVLO Evelo Biosciences IMUX Immunic KLDO Kaleido Biosciences PTGX Protagonist Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2

$80

3 years 3 months 27 days ago
(26-Jul-2023)

1/2 (50%)

$-5.88 (-74.62%)

83

Buy

$10

$10

3 years 8 months 5 days ago
(17-Mar-2023)

2/2 (100%)

$4.82 (93.05%)

79

Buy

$280

3 years 9 months 21 days ago
(01-Feb-2023)

1/3 (33.33%)

$120.6 (75.66%)

6

Buy

$41.5

5 years 20 days ago
(02-Nov-2021)

1/1 (100%)

$-162.5 (-79.66%)

190

Show more analysts

Stocks Gobind Singh covered previously. Scores are shown for active stocks only.

PRTA Prothena plc RPHM Reneo Pharmaceuticals

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?